Esa Kumpulainen

Title: Esa Kumpulainen: Innovator in Pharmaceutical Chemistry

Introduction

Esa Kumpulainen is a notable inventor based in Helsinki, Finland. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that target the central nervous system.

Latest Patents

Kumpulainen holds a patent for a compound titled "2-(1-heteroarylpiperazin-4-yl)methyl-1,4-benzodioxane derivatives as alpha2C antagonists." This patent describes compounds of formula I, wherein A is an optionally substituted five-membered unsaturated heterocyclic ring containing 1, 2, or 3 N, O, or S ring heteroatom(s). These compounds exhibit alpha2C antagonistic activity and are thus useful for the treatment of diseases or conditions of the peripheral or central nervous system. He has 1 patent to his name.

Career Highlights

Esa Kumpulainen is associated with Orion Corporation, a leading pharmaceutical company in Finland. His work focuses on innovative solutions for medical treatments, contributing to advancements in drug development.

Collaborations

Kumpulainen has collaborated with several professionals in his field, including Shouming Wang and Jarmo J Pystynen. These collaborations have enhanced the research and development efforts within his projects.

Conclusion

Esa Kumpulainen is a prominent figure in pharmaceutical innovation, with a focus on compounds that can significantly impact the treatment of neurological conditions. His contributions continue to shape the future of medical science.